Medtronic will use the assets to develop PEEK interbody fusion devices. The FDA-designated bone-growth nanotechnology uses osseointegration to enhance implant fixation.
“Combining our market-leading nano surface technology with Medtronic’s market-leading PEEK implant designs will give a growing number of surgeons access to best-in-class devices to treat patients,” Brian More, Nanovis’ CEO, said in the release.